STOCK TITAN

Eyenovia to Present at Upcoming Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Eyenovia, Inc. (Nasdaq: EYEN) has announced its participation in two upcoming healthcare conferences. The R.W. Baird Global Healthcare Conference will occur on September 14, 2022, with a presentation from 10:50 AM to 11:20 AM ET. The Ladenburg Thalmann Healthcare Conference is scheduled for September 29, 2022, with a presentation from 3:30 PM to 3:55 PM ET. Eyenovia is focused on developing advanced therapeutics using its microdose array print (MAP™) technology, targeting mydriasis, presbyopia, and myopia progression.

Positive
  • None.
Negative
  • None.

NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (Nasdaq: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced they will present at the R.W. Baird Global Healthcare Conference taking place on September 13-14, 2022 at the Intercontinental New York Barclay Hotel and the Ladenburg Thalmann Healthcare Conference taking place on September 29, 2022 at the Sofitel Hotel in New York City. Presentation details are below:

R.W. Baird Global Healthcare Conference

Date:Wednesday, September 14, 2022
Time:10:50 – 11:20 AM ET
Location:Session IV, Morgan Suite, Mezzanine Level

Ladenburg Thalmann Healthcare Conference

Date:Thursday, September 29, 2022
Time:3:30-3:55 PM ET
Location:Track 1 – Trocadero
Webcast:Here

The Eyenovia management team will be participating in one-on-one meetings at both events. Investors interested in meeting with Eyenovia at either conference should contact their respective bank representative.

About Eyenovia, Inc.

Eyenovia, Inc. (Nasdaq: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia and myopia progression. For more information, visit Eyenovia.com.

The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.

Eyenovia Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.com

Eyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363

Eyenovia Media Contact:
Norbert Lowe
Vice President, Commercial Operations
Eyenovia
nlowe@eyenovia.com


FAQ

When is Eyenovia presenting at the R.W. Baird Global Healthcare Conference?

Eyenovia will present on September 14, 2022, from 10:50 AM to 11:20 AM ET.

What is the focus of Eyenovia's presentation at the Ladenburg Thalmann Healthcare Conference?

Eyenovia will discuss their pipeline of advanced therapeutics based on their MAP™ platform technology.

What dates are the upcoming conferences for Eyenovia?

Eyenovia will attend the R.W. Baird conference on September 14, 2022, and the Ladenburg Thalmann conference on September 29, 2022.

Where will Eyenovia's presentations take place?

The R.W. Baird Global Healthcare Conference is at the Intercontinental New York Barclay Hotel, and the Ladenburg Thalmann conference is at the Sofitel Hotel in New York City.

What is the stock symbol for Eyenovia?

Eyenovia trades under the stock symbol EYEN on Nasdaq.

Eyenovia, Inc.

NASDAQ:EYEN

EYEN Rankings

EYEN Latest News

EYEN Stock Data

9.00M
77.81M
9.99%
13.73%
2.49%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NEW YORK